Drugs / Fortified Oral Rehydration Therapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06137014 | Jun 2024 → Dec 2026 expected | gastroenteritis | Paul A Breslin | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fortified Oral Rehydration Therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06137014 ↗ |
| Route | Oral | “Participants will consume the amino acid-fortified oral rehydration therapy” NCT06137014 ↗ |